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Abstract 
Review on t(6;12)(q22;q24), with data on the genes 
involved. 
Keywords 
Chromosome 6; Chromosome 12; t(6;12)(q22;q24); 
Anaplastic large cell lymphoma, ALK negative  
Clinics and pathology 
Disease 
Anaplastic large cell lymphoma, ALK negative 
Note 
Two available cases of t(6;12)(q22;q24) to date 
(Barbieri et al., 1984; Crescenzo et al., 2015). One 
case was a 39 year old patient (Barbieri et al., 1984). 
Prognosis 
No data 
Genes involved and 
proteins 
In one case of t(6;12)(q22;q24) a hybrid 




This gene encodes a nuclear receptor co-repressor 
that mediates transcriptional silencing of certain 
nuclear receptors by promoting chromatin 
condensation, thus preventing access of the basal 
transcription. Aberrant expression of NCOR2 is 




This proto-oncogene belongs to the subfamily of 
tyrosine kinase insulin receptor genes and expresses 
in a variety of tumor cell lines. ROS1 is an integral 
membrane protein with tyrosine kinase activity, that 
may function as a growth or differentiation factor 
receptor. 




Schematic of the structure of the NCOR2/ROS1 fusion. The N-term region of NCOR2 is fused to the intracytoplasmic region of 
ROS1. 










The chimeric NCOR2/ROS1 fusion may influence 
the transcriptional activity of the partner genes, 
perturbing transcription repression. This, in turn, 
may lead to a widespread derangement of several 
metabolic and signaling pathways ( STAT3), which 
concur to tumor transformation [Crescenzo et al, 
2015; Tabbo et al, 2016]. 
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